Logo image of GNLN

GREENLANE HOLDINGS INC - A (GNLN) Stock Fundamental Analysis

NASDAQ:GNLN - Nasdaq - US3953304009 - Common Stock - Currency: USD

0.74  0 (-0.66%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GNLN. GNLN was compared to 15 industry peers in the Distributors industry. While GNLN seems to be doing ok healthwise, there are quite some concerns on its profitability. GNLN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GNLN had negative earnings in the past year.
GNLN had a negative operating cash flow in the past year.
In the past 5 years GNLN always reported negative net income.
GNLN had a negative operating cash flow in each of the past 5 years.
GNLN Yearly Net Income VS EBIT VS OCF VS FCFGNLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -39.02%, GNLN is doing worse than 85.71% of the companies in the same industry.
Looking at the Return On Equity, with a value of -139.36%, GNLN is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
ROA -39.02%
ROE -139.36%
ROIC N/A
ROA(3y)-58.48%
ROA(5y)-41.21%
ROE(3y)-143.88%
ROE(5y)-131.25%
ROIC(3y)N/A
ROIC(5y)N/A
GNLN Yearly ROA, ROE, ROICGNLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400

1.3 Margins

GNLN's Gross Margin of 47.00% is amongst the best of the industry. GNLN outperforms 92.86% of its industry peers.
In the last couple of years the Gross Margin of GNLN has grown nicely.
The Profit Margin and Operating Margin are not available for GNLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.26%
GM growth 5Y6.44%
GNLN Yearly Profit, Operating, Gross MarginsGNLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60 -80

More info and screens

5

2. Health

2.1 Basic Checks

GNLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GNLN has less shares outstanding
Compared to 5 years ago, GNLN has less shares outstanding
Compared to 1 year ago, GNLN has a worse debt to assets ratio.
GNLN Yearly Shares OutstandingGNLN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
GNLN Yearly Total Debt VS Total AssetsGNLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -11.33, we must say that GNLN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -11.33, GNLN is doing worse than 92.86% of the companies in the same industry.
GNLN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.33
ROIC/WACCN/A
WACC28.45%
GNLN Yearly LT Debt VS Equity VS FCFGNLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.10 indicates that GNLN should not have too much problems paying its short term obligations.
GNLN has a worse Current ratio (1.10) than 85.71% of its industry peers.
GNLN has a Quick Ratio of 1.10. This is a bad value and indicates that GNLN is not financially healthy enough and could expect problems in meeting its short term obligations.
GNLN has a worse Quick ratio (0.44) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.44
GNLN Yearly Current Assets VS Current LiabilitesGNLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.53% over the past year.
GNLN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -72.07%.
The Revenue for GNLN have been decreasing by -18.24% on average. This is quite bad
EPS 1Y (TTM)55.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.12%
Revenue 1Y (TTM)-72.07%
Revenue growth 3Y-22.1%
Revenue growth 5Y-18.24%
Sales Q2Q%-65.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
GNLN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 51.19% yearly.
EPS Next Y62.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.16%
Revenue Next 2Y51.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GNLN Yearly Revenue VS EstimatesGNLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
GNLN Yearly EPS VS EstimatesGNLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GNLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNLN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNLN Price Earnings VS Forward Price EarningsGNLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNLN Per share dataGNLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GNLN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLANE HOLDINGS INC - A

NASDAQ:GNLN (2/21/2025, 12:15:32 PM)

0.74

0 (-0.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)01-07 2025-01-07
Earnings (Next)07-16 2025-07-16/amc
Inst Owners0.79%
Inst Owner Change498.29%
Ins Owners0.43%
Ins Owner Change0%
Market Cap1.47M
Analysts43.33
Price TargetN/A
Short Float %2.19%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.15
P/tB 0.15
EV/EBITDA N/A
EPS(TTM)-19.6
EYN/A
EPS(NY)-5.62
Fwd EYN/A
FCF(TTM)-4.43
FCFYN/A
OCF(TTM)-4.15
OCFYN/A
SpS10.91
BVpS4.78
TBVpS4.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.02%
ROE -139.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47%
FCFM N/A
ROA(3y)-58.48%
ROA(5y)-41.21%
ROE(3y)-143.88%
ROE(5y)-131.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.26%
GM growth 5Y6.44%
F-Score4
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.47%
Cap/Sales 2.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.44
Altman-Z -11.33
F-Score4
WACC28.45%
ROIC/WACCN/A
Cap/Depr(3y)56.45%
Cap/Depr(5y)62.99%
Cap/Sales(3y)2.07%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.12%
EPS Next Y62.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-72.07%
Revenue growth 3Y-22.1%
Revenue growth 5Y-18.24%
Sales Q2Q%-65.78%
Revenue Next Year18.16%
Revenue Next 2Y51.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.43%
OCF growth 3YN/A
OCF growth 5YN/A